Guggenheim Initiates Coverage On Veracyte with Buy Rating, Announces Price Target of $40
Portfolio Pulse from Benzinga Newsdesk
Guggenheim has initiated coverage on Veracyte (NASDAQ:VCYT) with a Buy rating and set a price target of $40.
October 10, 2024 | 3:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Guggenheim has initiated coverage on Veracyte with a Buy rating and a price target of $40, indicating a positive outlook for the stock.
The initiation of coverage with a Buy rating and a specific price target by a reputable firm like Guggenheim is likely to positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100